Clear Guide Medical

Clear Guide Medical

Baltimore, United States· Est. 2012

Clear Guide Medical is a leader in next-generation navigation technology for image fusion and augmented reality in interventional procedures. The company's patented SuperPROBE platform, integrated into products like CLEAR GUIDE SCENERGY and Lumena, uses computer vision to guide instruments directly from an ultrasound transducer, making procedures more efficient and cost-effective. As a Johns Hopkins spinout with FDA clearances, CE Mark, and ongoing clinical trials, the company is positioned to expand its commercial footprint in the growing market for image-guided interventions.

Private Company

Total funding raised: $17M

AI Company Overview

Clear Guide Medical is a leader in next-generation navigation technology for image fusion and augmented reality in interventional procedures. The company's patented SuperPROBE platform, integrated into products like CLEAR GUIDE SCENERGY and Lumena, uses computer vision to guide instruments directly from an ultrasound transducer, making procedures more efficient and cost-effective. As a Johns Hopkins spinout with FDA clearances, CE Mark, and ongoing clinical trials, the company is positioned to expand its commercial footprint in the growing market for image-guided interventions.

OncologyPain ManagementInterventional Radiology

Technology Platform

Patented SuperPROBE platform using computer vision and AI for real-time instrument guidance and image fusion directly from an ultrasound transducer, compatible with MRI, CT, and standard ultrasound systems.

Funding History

2
Total raised:$17M
Series B$10MApr 15, 2019
Series A$7MSep 15, 2016

Opportunities

Significant growth opportunity lies in expanding international sales and leveraging the upcoming Phase 2 data for Lumena to drive adoption in ablation procedures.
The system's value in training novice operators presents a strong entry point into teaching hospitals and residency programs globally.

Risk Factors

Key risks include intense competition from large, established medtech players, the challenge of changing clinical workflows to adopt new technology, and dependence on securing additional growth capital to fund international expansion and commercial scaling.

Competitive Landscape

Competes against established navigation systems from Philips (PercuNav), Siemens, GE, and Medtronic. Key differentiation is the transducer-based SuperPROBE platform that requires no external trackers and is compatible with any ultrasound system, offering a potentially more cost-effective and flexible solution.